Kestra Advisory Services, LLC Vertex Pharmaceuticals Inc Transaction History

Kestra Advisory Services, LLC

$17.6 Billion
Q2 2024

A detailed history of Kestra Advisory Services, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Kestra Advisory Services, LLC holds 19,744 shares of VRTX stock, worth $9.92 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

19,744

Previous 20,441 3.41%

Holding current value

$9.92 Million

Previous $8.54 Million 8.31%

% of portfolio

0.05%

Previous 0.06%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $273,788 - $338,414	-697 Reduced 3.41%	19,744 $9.25 Million
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $988,648 - $1.08 Million	2,425 Added 13.46%	20,441 $8.54 Million
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $770,035 - $921,976	2,245 Added 14.23%	18,016 $7.33 Million
Q3 2023 Nov 09, 2023	BUY	$338.18 - $362.46 $156,915 - $168,181	464 Added 3.03%	15,771 $5.48 Million
Q2 2023 Aug 11, 2023	BUY	$314.42 - $351.91 $977,846 - $1.09 Million	3,110 Added 25.5%	15,307 $5.39 Million
Q1 2023 May 12, 2023	SELL	$283.23 - $323.1 $2.77 Million - $3.16 Million	-9,768 Reduced 44.47%	12,197 $3.84 Million
Q4 2022 Jan 31, 2023	BUY	$285.76 - $321.48 $788,983 - $887,606	2,761 Added 14.38%	21,965 $6.34 Million
Q3 2022 Nov 01, 2022	SELL	$273.83 - $305.53 $772,748 - $862,205	-2,822 Reduced 12.81%	19,204 $5.56 Billion
Q2 2022 Aug 12, 2022	SELL	$234.96 - $292.55 $557,090 - $693,636	-2,371 Reduced 9.72%	22,026 $6.21 Million
Q1 2022 Apr 26, 2022	BUY	$221.42 - $260.97 $1.27 Million - $1.49 Million	5,720 Added 30.63%	24,397 $6.37 Million
Q4 2021 Jan 20, 2022	SELL	$177.01 - $223.45 $318,972 - $402,656	-1,802 Reduced 8.8%	18,677 $4.1 Million
Q3 2021 Oct 19, 2021	SELL	$181.39 - $202.99 $420,824 - $470,936	-2,320 Reduced 10.18%	20,479 $3.71 Million
Q2 2021 Jul 28, 2021	SELL	$187.49 - $221.1 $177,740 - $209,602	-948 Reduced 3.99%	22,799 $4.6 Million
Q1 2021 May 10, 2021	BUY	$207.02 - $241.31 $3.83 Million - $4.46 Million	18,503 Added 352.84%	23,747 $5.1 Million
Q4 2020 Jan 20, 2021	BUY	$207.01 - $276.09 $1.07 Million - $1.42 Million	5,158 Added 5997.67%	5,244 $1.22 Billion
Q3 2020 Nov 12, 2020	BUY	$255.65 - $303.1 $21,985 - $26,066	86 New	86 $1.45 Billion

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Advisory Services, LLC with notifications on news.

Account

Kestra Advisory Services, LLC Vertex Pharmaceuticals Inc Transaction History